Clinical Trials Directory

Trials / Sponsors / Nanjing Legend Biotech Co.

Nanjing Legend Biotech Co.

Industry · 7 registered clinical trials — 4 currently recruiting.

StatusTrialPhaseStarted
RecruitingA Study of LUCAR-G79D in Subjects With Relapsed/Refractory Systemic Lupus Erythematosus (r/r SLE) and Idiopath
Systemic Lupus Erythematosus (SLE), Idiopathic Inflammatory Myopathies(IIM)
Phase 12026-01-29
RecruitingA Study of LUCAR-DKS1 in Subjects With Relapsed/Refractory Autoimmune Diseases
Relapsed/Refractory Autoimmune Diseases
EARLY_Phase 12025-10-14
RecruitingLCAR-F33S in Treatment of Relapsed/Refractory Multiple Myeloma
Relapsed/Refractory Multiple Myeloma(MM)
N/A2025-09-16
RecruitingA Study of LUCAR-G79 in Subjects With Relapsed/Refractory Autoimmune Diseases
Relapsed/Refractory Autoimmune Diseases
Phase 12025-07-17
WithdrawnA Study of LCAR-AIO in Subjects With Relapsed/Refractory Autoimmune Diseases
Relapsed/Refractory Autoimmune Diseases
EARLY_Phase 12025-06-17
TerminatedA Study of LCAR-B38M CAR-T Cells, a Chimeric Antigen Receptor T-cell (CAR-T) Therapy Directed Against B-cell M
Multiple Myeloma
Phase 22019-01-23
UnknownLCAR-B38M Cells in Treating Relapsed/Refractory (R/R) Multiple Myeloma
Refractory or Relapsed Multiple Myeloma
Phase 1 / Phase 22015-10-02